Index S&P 500
P/E 62.22
EPS (ttm) 1.46
Insider Own 0.51%
Shs Outstand 198.00M
Perf Week 2.03%
Market Cap 18.02B
Forward P/E 22.94
EPS next Y 3.95
Insider Trans -27.10%
Shs Float 197.74M
Perf Month -8.59%
Income 290.80M
PEG 5.53
EPS next Q 0.83
Inst Own 99.10%
Short Float 1.09%
Perf Quarter -3.65%
Sales 3.67B
P/S 4.91
EPS this Y 10.80%
Inst Trans -1.06%
Short Ratio 1.89
Perf Half Y 14.40%
Book/sh 38.73
P/B 2.34
EPS next Y 11.37%
ROA 2.47%
Short Interest 2.15M
Perf Year -4.82%
Cash/sh 0.68
P/C 133.15
EPS next 5Y 11.25%
ROE 3.87%
52W Range 75.93 - 104.07
Perf YTD -4.20%
Dividend Est. -
P/FCF 132.47
EPS past 5Y 15.98%
ROI 2.79%
52W High -12.90%
Beta 1.02
Dividend TTM 0.03 (0.03%)
Quick Ratio 1.08
Sales past 5Y 7.68%
Gross Margin 60.91%
52W Low 19.37%
ATR (14) 1.80
Dividend Ex-Date Jul 26, 2023
Current Ratio 1.86
EPS Y/Y TTM -22.82%
Oper. Margin 14.64%
RSI (14) 39.98
Volatility 1.80% 1.84%
Employees 15000
Debt/Eq 0.36
Sales Y/Y TTM 8.48%
Profit Margin 7.93%
Recom 2.10
Target Price 110.01
Option/Short Yes / Yes
LT Debt/Eq 0.35
EPS Q/Q -4.56%
Payout -
Rel Volume 0.67
Prev Close 89.75
Sales Surprise 1.71%
EPS Surprise 8.49%
Sales Q/Q 8.51%
Earnings Feb 29 AMC
Avg Volume 1.14M
Price 90.64
SMA20 -1.72%
SMA50 -6.40%
SMA200 -0.24%
Trades
Volume 766,922
Change 0.99%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-19-24 Upgrade
Redburn Atlantic
Neutral → Buy
$125
Mar-13-24 Upgrade
JP Morgan
Neutral → Overweight
$100 → $120
Feb-06-24 Resumed
KeyBanc Capital Markets
Sector Weight
Oct-30-23 Initiated
BofA Securities
Buy
$380
Oct-05-23 Downgrade
Redburn Atlantic
Overweight → Neutral
$390 → $343
May-30-23 Initiated
Morgan Stanley
Equal-Weight
$410
Dec-22-22 Initiated
Mizuho
Buy
$375
Nov-30-22 Upgrade
Robert W. Baird
Neutral → Outperform
$345 → $375
Oct-12-22 Downgrade
Jefferies
Buy → Hold
$400 → $295
Aug-29-22 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
May-17-22 Upgrade
Citigroup
Neutral → Buy
$460 → $405
Apr-08-22 Initiated
Needham
Hold
Jan-03-22 Upgrade
Guggenheim
Neutral → Buy
Sep-03-21 Reiterated
Stifel
Buy
$450 → $475
Sep-03-21 Reiterated
Oppenheimer
Perform
$405 → $475
Sep-03-21 Reiterated
KeyBanc Capital Markets
Overweight
$444 → $476
Sep-03-21 Reiterated
Citigroup
Neutral
$400 → $453
Apr-23-21 Initiated
Redburn
Buy
Jul-06-20 Downgrade
Robert W. Baird
Outperform → Neutral
$291
Mar-05-20 Initiated
Citigroup
Neutral
$360
Show Previous Ratings
Apr-30-24 04:15PM
Apr-24-24 12:00PM
Apr-12-24 09:22AM
Mar-25-24 02:16PM
Mar-11-24 08:27AM
02:37PM
Loading…
Mar-08-24 02:37PM
Mar-01-24 10:41AM
(Morningstar Research) +9.18%
07:07AM
Feb-29-24 04:15PM
Feb-26-24 09:16AM
Feb-22-24 10:00AM
Feb-21-24 08:01PM
Feb-20-24 11:35AM
Feb-18-24 01:26PM
Feb-15-24 04:15PM
09:43AM
Loading…
Feb-13-24 09:43AM
Feb-12-24 10:31AM
08:02AM
Feb-09-24 08:31AM
Jan-25-24 04:15PM
Jan-22-24 04:53AM
Jan-05-24 07:48AM
Dec-21-23 04:15PM
Dec-19-23 04:15PM
Dec-09-23 01:05AM
Dec-08-23 02:11PM
12:57PM
(Associated Press Finance)
09:17AM
09:14AM
07:15AM
(Thomson Reuters StreetEvents)
06:00PM
Loading…
Dec-07-23 06:00PM
05:10PM
04:58PM
04:36PM
(Associated Press Finance)
04:15PM
Dec-05-23 02:20PM
Dec-04-23 12:44PM
Nov-30-23 04:15PM
10:00AM
Nov-28-23 09:31AM
Nov-24-23 01:25AM
Nov-02-23 04:15PM
Nov-01-23 04:15PM
Oct-30-23 09:43AM
Oct-19-23 11:40AM
Oct-13-23 11:33AM
07:36AM
Sep-27-23 12:03PM
Sep-14-23 12:30PM
Sep-12-23 04:15PM
Sep-11-23 04:15PM
Sep-08-23 03:44PM
Sep-05-23 12:03PM
Aug-31-23 12:06PM
11:35AM
10:14AM
08:39AM
08:19AM
06:41AM
(Thomson Reuters StreetEvents)
Aug-30-23 06:00PM
06:00PM
05:25PM
04:25PM
04:15PM
Aug-29-23 08:46AM
Aug-28-23 11:43AM
Aug-25-23 08:02AM
Aug-24-23 12:10PM
Aug-15-23 03:41PM
Aug-13-23 08:23AM
Aug-10-23 09:05PM
Aug-09-23 06:46AM
Aug-07-23 01:18PM
Aug-02-23 04:14PM
Jul-27-23 04:33PM
Jul-26-23 04:15PM
Jul-17-23 07:05AM
04:37AM
Jul-13-23 02:00PM
10:00AM
Jul-12-23 04:15PM
11:40AM
Jul-03-23 10:30AM
Jun-28-23 10:19AM
Jun-23-23 11:40AM
Jun-21-23 08:00PM
Jun-15-23 07:52PM
Jun-09-23 07:13PM
Jun-07-23 11:40AM
Jun-06-23 03:39PM
Jun-05-23 09:35AM
07:21AM
Jun-02-23 05:45PM
02:07PM
(Thomson Reuters StreetEvents)
11:35AM
10:05AM
Jun-01-23 06:00PM
05:35PM
04:26PM
04:15PM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rivas Maria Director Apr 01 '24 Option Exercise 0.00 2,892 0 2,892 Apr 03 06:03 PM WEISS ROBERT S Director Apr 01 '24 Option Exercise 0.00 3,180 0 285,952 Apr 03 06:03 PM Jay Colleen Director Apr 01 '24 Option Exercise 0.00 2,892 0 26,800 Apr 03 05:53 PM Lucchese Cynthia L Director Apr 01 '24 Option Exercise 0.00 2,892 0 4,940 Apr 03 05:53 PM MADDEN TERESA S Director Apr 01 '24 Option Exercise 0.00 2,892 0 9,636 Apr 03 05:53 PM KOZY WILLIAM A Director Apr 01 '24 Option Exercise 0.00 3,036 0 28,292 Apr 03 05:52 PM Kurzius Lawrence Erik Director Apr 01 '24 Option Exercise 0.00 1,056 0 1,056 Apr 03 05:52 PM Ricupati Agostino SVP & CAO Mar 18 '24 Option Exercise 69.74 54,724 3,816,317 34,609 Mar 20 06:58 PM Ricupati Agostino SVP & CAO Mar 18 '24 Sale 100.89 54,724 5,521,230 5,081 Mar 20 06:58 PM WEISS ROBERT S Director Mar 08 '24 Option Exercise 57.41 88,075 5,056,826 370,847 Mar 11 05:00 PM WEISS ROBERT S Director Mar 08 '24 Sale 102.18 88,075 8,999,732 282,772 Mar 11 05:00 PM WEISS ROBERT S Director Mar 07 '24 Option Exercise 57.41 153,213 8,796,724 435,985 Mar 11 05:00 PM WEISS ROBERT S Director Mar 07 '24 Sale 102.21 153,213 15,659,610 282,772 Mar 11 05:00 PM PETERSMEYER GARY S Director Mar 05 '24 Sale 103.51 1,000 103,506 5,668 Mar 07 06:05 PM Andrews Brian G EVP, CFO & Treasurer Jan 08 '24 Option Exercise 0.00 723 0 2,996 Jan 10 07:11 PM Warner Gerard H III President, CooperVision, Inc. Jan 08 '24 Option Exercise 0.00 2,738 0 4,028 Jan 10 07:11 PM McBride Daniel G EVP & Chief Operating Officer Jan 08 '24 Option Exercise 0.00 1,042 0 9,368 Jan 10 07:11 PM Ricupati Agostino SVP & CAO Jan 08 '24 Option Exercise 0.00 786 0 1,710 Jan 10 07:11 PM Khadder Nicholas VP, General Counsel & Corp Sec Jan 08 '24 Option Exercise 0.00 284 0 325 Jan 10 07:11 PM Sheffield Holly R President, CSI Jan 08 '24 Option Exercise 0.00 986 0 5,564 Jan 10 07:11 PM PETERSMEYER GARY S Director Jan 04 '24 Sale 336.03 150 50,404 2,297 Jan 05 06:05 PM WEISS ROBERT S Director Dec 19 '23 Option Exercise 175.31 79,370 13,914,355 150,063 Dec 21 05:25 PM WEISS ROBERT S Director Dec 19 '23 Sale 364.81 79,370 28,955,135 70,693 Dec 21 05:25 PM PETERSMEYER GARY S Director Dec 14 '23 Sale 368.55 300 110,565 2,464 Dec 14 07:15 PM Sheffield Holly R President, CSI Jun 04 '23 Option Exercise 356.47 1,104 393,543 4,952 Jun 07 02:45 PM
Index RUT
P/E 105.27
EPS (ttm) 0.43
Insider Own 0.78%
Shs Outstand 48.84M
Perf Week -3.09%
Market Cap 2.24B
Forward P/E 50.33
EPS next Y 0.90
Insider Trans 339.58%
Shs Float 48.75M
Perf Month 0.00%
Income 21.35M
PEG 3.51
EPS next Q 0.05
Inst Own 104.14%
Short Float 10.00%
Perf Quarter 63.59%
Sales 322.42M
P/S 6.93
EPS this Y -39.64%
Inst Trans 1.93%
Short Ratio 6.82
Perf Half Y 5.06%
Book/sh 7.90
P/B 5.76
EPS next Y 48.32%
ROA 4.72%
Short Interest 4.87M
Perf Year -35.07%
Cash/sh 4.49
P/C 10.13
EPS next 5Y 30.00%
ROE 5.95%
52W Range 26.66 - 73.03
Perf YTD 45.82%
Dividend Est. -
P/FCF -
EPS past 5Y 31.51%
ROI 5.11%
52W High -37.68%
Beta 0.69
Dividend TTM -
Quick Ratio 5.08
Sales past 5Y 21.55%
Gross Margin 78.36%
52W Low 70.73%
ATR (14) 1.99
Dividend Ex-Date -
Current Ratio 5.62
EPS Y/Y TTM -45.63%
Oper. Margin 8.71%
RSI (14) 52.22
Volatility 3.36% 4.28%
Employees 1115
Debt/Eq 0.09
Sales Y/Y TTM 13.37%
Profit Margin 6.62%
Recom 1.92
Target Price 49.17
Option/Short Yes / Yes
LT Debt/Eq 0.08
EPS Q/Q 32.91%
Payout 0.00%
Rel Volume 0.51
Prev Close 45.54
Sales Surprise 0.43%
EPS Surprise -27.29%
Sales Q/Q 19.09%
Earnings May 07 AMC
Avg Volume 715.21K
Price 45.51
SMA20 -4.72%
SMA50 11.20%
SMA200 17.81%
Trades
Volume 367,231
Change -0.07%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-24 Upgrade
Stifel
Hold → Buy
$30 → $50
Dec-05-23 Downgrade
Needham
Buy → Hold
Dec-04-23 Initiated
Morgan Stanley
Equal-Weight
$35
Sep-15-23 Downgrade
The Benchmark Company
Buy → Hold
Aug-03-23 Downgrade
Canaccord Genuity
Buy → Hold
$77 → $48
Jun-07-23 Downgrade
William Blair
Outperform → Mkt Perform
Apr-17-23 Initiated
Piper Sandler
Neutral
$65
Feb-06-23 Downgrade
BTIG Research
Buy → Neutral
Dec-28-22 Reiterated
BTIG Research
Buy
$80 → $67
Dec-08-22 Initiated
Stifel
Hold
$60
Nov-07-22 Upgrade
Sidoti
Neutral → Buy
Oct-14-22 Resumed
Stephens
Overweight
$91
Oct-13-22 Initiated
Mizuho
Buy
$85
Apr-08-22 Initiated
Needham
Buy
$87
Mar-28-22 Upgrade
The Benchmark Company
Hold → Buy
$97
Mar-18-22 Upgrade
BTIG Research
Neutral → Buy
$98
Jul-09-21 Initiated
Oppenheimer
Perform
$150
Jan-19-21 Downgrade
The Benchmark Company
Buy → Hold
Oct-26-20 Downgrade
Sidoti
Buy → Neutral
Aug-31-20 Upgrade
Sidoti
Neutral → Buy
$58
Show Previous Ratings
May-01-24 07:00AM
Apr-29-24 07:00AM
Apr-25-24 03:43PM
(Investor's Business Daily)
Apr-05-24 09:15AM
Apr-04-24 04:26PM
(Investor's Business Daily) +16.48%
03:54PM
Loading…
03:54PM
07:00AM
Apr-02-24 07:00AM
Mar-26-24 11:45AM
Mar-20-24 04:22AM
Mar-18-24 07:00AM
Mar-12-24 10:30AM
07:00AM
Mar-06-24 07:00AM
Feb-28-24 10:58AM
02:00PM
Loading…
Feb-27-24 02:00PM
Feb-26-24 05:30PM
04:39PM
(Associated Press Finance)
04:34PM
04:01PM
Feb-19-24 07:00AM
Jan-27-24 01:03PM
Jan-23-24 07:00AM
Jan-12-24 06:49PM
Jan-08-24 07:00AM
Dec-17-23 12:35PM
Dec-05-23 03:16AM
Dec-04-23 04:05PM
Nov-15-23 07:00AM
Nov-02-23 05:50PM
09:23AM
Loading…
09:23AM
(Thomson Reuters StreetEvents)
Nov-01-23 06:30PM
05:56PM
04:17PM
(Associated Press Finance)
04:01PM
Oct-31-23 04:40PM
Oct-18-23 04:05PM
Oct-17-23 07:00AM
Oct-13-23 06:30PM
Oct-10-23 10:51AM
Sep-19-23 11:51AM
Sep-15-23 09:32AM
Sep-14-23 12:53PM
07:00AM
Sep-08-23 11:38AM
Sep-07-23 05:00PM
Aug-18-23 10:40AM
Aug-17-23 06:48PM
Aug-09-23 07:00AM
Aug-07-23 07:00AM
05:00AM
Aug-03-23 07:18PM
Aug-02-23 05:25PM
04:21PM
04:01PM
Jul-19-23 07:00AM
Jun-21-23 08:00PM
Jun-13-23 08:00AM
May-26-23 06:00AM
May-17-23 10:10AM
May-09-23 01:48PM
May-04-23 07:00AM
May-03-23 05:35PM
04:29PM
04:01PM
Apr-27-23 10:02AM
Apr-26-23 08:00PM
10:02AM
Apr-23-23 08:25AM
Apr-19-23 07:00AM
Apr-07-23 11:44AM
Apr-04-23 06:00PM
Mar-29-23 06:00PM
07:00AM
Mar-23-23 06:00PM
Mar-15-23 05:50PM
Mar-13-23 08:48AM
Mar-09-23 05:25AM
Feb-23-23 05:12AM
Feb-21-23 05:15PM
04:01PM
Feb-13-23 05:50PM
Feb-07-23 07:00AM
Feb-03-23 05:50PM
01:58PM
09:00AM
Jan-31-23 09:25AM
Jan-25-23 06:00PM
Jan-24-23 03:26PM
Jan-17-23 06:00PM
Jan-11-23 07:00AM
Jan-10-23 06:41AM
Jan-09-23 07:00AM
Jan-06-23 09:13PM
01:52PM
Dec-30-22 07:17AM
Dec-20-22 08:56AM
Dec-19-22 08:15AM
Dec-13-22 11:01AM
Nov-28-22 01:18PM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
WEISNER AIMEE S Director Mar 14 '24 Buy 38.11 1,750 66,692 10,864 Mar 14 05:23 PM Williams Patrick F. Chief Financial Officer Mar 07 '24 Option Exercise 0.00 2,614 0 45,475 Mar 11 06:06 AM BROADWOOD PARTNERS, L.P. 10% Owner Jan 08 '24 Buy 27.11 4,042 109,570 10,768,430 Jan 10 05:44 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 05 '24 Buy 28.48 156,734 4,463,231 10,764,388 Jan 05 07:07 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 04 '24 Buy 28.91 63,246 1,828,183 10,607,654 Jan 05 07:07 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 03 '24 Buy 28.93 6,573 190,144 10,544,408 Jan 05 07:07 PM Zhou Lilian Yansheng Director Dec 06 '23 Buy 30.74 850 26,129 2,327 Dec 06 04:11 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 30 '23 Buy 31.42 177,707 5,583,678 10,537,835 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 29 '23 Buy 31.39 160,300 5,031,358 10,360,128 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 28 '23 Buy 31.85 96,984 3,088,794 10,199,828 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 13 '23 Buy 33.04 507 16,749 10,102,844 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 10 '23 Buy 32.73 34,320 1,123,383 10,102,337 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 09 '23 Buy 33.09 140,000 4,632,581 10,068,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 08 '23 Buy 33.71 139,409 4,699,073 9,928,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 07 '23 Buy 34.03 9,731 331,127 9,788,608 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 06 '23 Buy 34.16 164,607 5,623,518 9,778,877 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 03 '23 Buy 36.06 520 18,753 9,614,270 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 02 '23 Buy 35.79 144,027 5,155,243 9,613,750 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 06 '23 Buy 37.62 75,299 2,832,417 9,469,723 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 05 '23 Buy 37.92 97,474 3,696,399 9,394,424 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 04 '23 Buy 37.93 32,523 1,233,649 9,296,950 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 21 '23 Buy 39.62 154,814 6,133,467 9,264,427 Sep 21 08:31 PM Lin Elizabeth Yeu Director Sep 21 '23 Buy 40.00 2,500 100,000 2,855 Sep 22 07:18 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 20 '23 Buy 40.67 132,079 5,372,274 9,109,613 Sep 21 08:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 19 '23 Buy 40.89 4,490 183,613 8,977,534 Sep 21 08:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 07 '23 Buy 41.26 60,874 2,511,722 8,973,044 Sep 07 07:00 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 06 '23 Buy 41.43 108,944 4,513,735 8,912,170 Sep 07 07:00 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 05 '23 Buy 41.87 20,144 843,455 8,803,226 Sep 07 07:00 PM Williams Patrick F. Chief Financial Officer Aug 10 '23 Option Exercise 0.00 5,122 0 45,400 Aug 11 06:01 PM WEISNER AIMEE S Director Aug 07 '23 Buy 48.72 2,000 97,440 5,417 Aug 07 04:16 PM Kliman Gilbert H Director Jun 15 '23 Option Exercise 0.00 3,417 0 9,656 Jun 16 08:39 PM WEISNER AIMEE S Director Jun 15 '23 Option Exercise 0.00 3,417 0 3,417 Jun 16 08:37 PM Yu K Peony Director Jun 15 '23 Option Exercise 0.00 1,709 0 2,786 Jun 16 08:35 PM FARRELL STEPHEN C Director Jun 15 '23 Option Exercise 0.00 1,709 0 8,276 Jun 16 08:41 PM Williams Patrick F. Chief Financial Officer Jun 06 '23 Option Exercise 0.00 5,121 0 47,387 Jun 07 04:53 PM Michna Magda Chief Clinical, Regulatory, May 08 '23 Option Exercise 0.00 14,047 0 14,047 May 09 05:26 PM Foust Warren Chief Operating Officer May 08 '23 Option Exercise 0.00 20,331 0 20,331 May 09 05:24 PM
Index RUT
P/E -
EPS (ttm) -0.85
Insider Own 1.94%
Shs Outstand 78.31M
Perf Week 0.11%
Market Cap 1.41B
Forward P/E 22.89
EPS next Y 0.78
Insider Trans 0.00%
Shs Float 77.03M
Perf Month -11.82%
Income -65.90M
PEG -
EPS next Q 0.27
Inst Own 109.52%
Short Float 10.15%
Perf Quarter -11.52%
Sales 2.13B
P/S 0.66
EPS this Y -14.31%
Inst Trans -1.61%
Short Ratio 7.77
Perf Half Y 14.74%
Book/sh 10.59
P/B 1.69
EPS next Y 42.57%
ROA -2.77%
Short Interest 7.82M
Perf Year -18.34%
Cash/sh 1.91
P/C 9.38
EPS next 5Y 7.70%
ROE -7.62%
52W Range 13.71 - 27.02
Perf YTD -14.48%
Dividend Est. -
P/FCF 25.59
EPS past 5Y -
ROI -3.98%
52W High -33.75%
Beta 1.52
Dividend TTM -
Quick Ratio 0.70
Sales past 5Y 7.09%
Gross Margin 48.31%
52W Low 30.56%
ATR (14) 0.77
Dividend Ex-Date -
Current Ratio 1.00
EPS Y/Y TTM -262.29%
Oper. Margin 1.49%
RSI (14) 36.00
Volatility 4.60% 3.85%
Employees 13998
Debt/Eq 1.11
Sales Y/Y TTM 6.04%
Profit Margin -3.10%
Recom 2.36
Target Price 23.80
Option/Short Yes / Yes
LT Debt/Eq 1.00
EPS Q/Q 1.59%
Payout -
Rel Volume 1.03
Prev Close 17.57
Sales Surprise 1.26%
EPS Surprise 76.25%
Sales Q/Q 7.99%
Earnings May 08 BMO
Avg Volume 1.01M
Price 17.90
SMA20 -4.57%
SMA50 -14.29%
SMA200 -7.15%
Trades
Volume 1,032,634
Change 1.88%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-17-23 Downgrade
Goldman
Buy → Neutral
$25 → $16
Jul-27-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$30 → $21
Jul-27-23 Downgrade
Citigroup
Buy → Neutral
$28 → $22
May-02-23 Downgrade
Barclays
Overweight → Equal Weight
Mar-31-23 Upgrade
Loop Capital
Hold → Buy
$23
Jan-17-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Nov-07-22 Resumed
Jefferies
Buy
$40 → $45
Jun-27-22 Upgrade
Goldman
Neutral → Buy
$31 → $32
Nov-15-21 Downgrade
Goldman
Buy → Neutral
$59 → $57
Nov-12-21 Downgrade
BofA Securities
Buy → Underperform
$63 → $50
Oct-14-21 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$70
Aug-27-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$58 → $57
Jan-11-21 Downgrade
Loop Capital
Buy → Hold
Nov-18-20 Downgrade
Berenberg
Buy → Hold
$42
Feb-04-20 Initiated
BMO Capital Markets
Market Perform
Feb-03-20 Initiated
BMO Capital Markets
Market Perform
Nov-13-19 Initiated
Barclays
Overweight
$34
Oct-01-19 Upgrade
BofA/Merrill
Neutral → Buy
Aug-07-19 Upgrade
Loop Capital
Hold → Buy
$30 → $37
Jul-11-19 Initiated
Goldman
Buy
$33
Show Previous Ratings
May-02-24 06:16AM
May-01-24 10:01AM
Apr-28-24 07:00AM
Apr-24-24 08:00AM
Apr-19-24 04:44AM
03:41AM
Loading…
Apr-17-24 03:41AM
Apr-08-24 06:56AM
05:12AM
Mar-28-24 11:30AM
Mar-21-24 08:10AM
Mar-12-24 08:30AM
Mar-06-24 07:30AM
Feb-29-24 08:01AM
Feb-28-24 09:04AM
Feb-27-24 11:19PM
(Thomson Reuters StreetEvents) +15.78%
06:23AM
Loading…
06:23AM
(Associated Press Finance)
06:15AM
06:12AM
06:10AM
06:00AM
Feb-13-24 08:00AM
Feb-08-24 08:00AM
Jan-30-24 09:00AM
Jan-26-24 08:00AM
Jan-22-24 03:04AM
Jan-19-24 12:14AM
Jan-17-24 08:00AM
Jan-15-24 01:26AM
Jan-12-24 07:19AM
Jan-09-24 08:35AM
06:59AM
Loading…
Dec-07-23 06:59AM
Nov-10-23 02:10PM
08:08AM
07:34AM
Nov-09-23 07:04AM
06:39AM
06:37AM
(Associated Press Finance)
06:28AM
06:00AM
Oct-31-23 08:00AM
Oct-26-23 08:00AM
Oct-19-23 08:30AM
Oct-05-23 04:31PM
Sep-11-23 11:21AM
Sep-05-23 04:05PM
Aug-11-23 08:48AM
Aug-10-23 10:47PM
(Thomson Reuters StreetEvents) -5.54%
09:08AM
06:25AM
(Associated Press Finance)
06:00AM
Aug-09-23 08:32AM
Aug-02-23 12:00PM
Jul-26-23 04:05PM
Jul-20-23 09:00AM
Jul-13-23 04:05PM
Jul-06-23 09:00AM
Jul-01-23 10:30AM
Jun-30-23 10:50PM
Jun-21-23 09:42AM
Jun-05-23 10:26AM
Jun-01-23 08:00AM
May-19-23 06:01AM
May-12-23 11:48AM
07:51AM
12:19AM
(Thomson Reuters StreetEvents)
May-11-23 06:12AM
06:00AM
May-09-23 02:32AM
May-07-23 09:43AM
May-04-23 06:26AM
May-02-23 08:02AM
May-01-23 09:00AM
Apr-27-23 08:00AM
Apr-17-23 04:17PM
Apr-05-23 12:03PM
Mar-22-23 11:52AM
Mar-08-23 08:00AM
07:04AM
Mar-03-23 08:00AM
Mar-02-23 11:28AM
03:26AM
(Thomson Reuters StreetEvents)
Mar-01-23 02:27PM
02:00PM
06:00AM
Feb-23-23 08:44AM
Feb-15-23 08:00AM
Jan-22-23 08:49AM
Dec-29-22 09:35AM
Dec-27-22 09:00AM
Dec-20-22 10:41AM
Nov-27-22 09:43AM
Nov-15-22 10:00AM
08:00AM
Nov-12-22 07:45AM
Nov-10-22 07:15AM
06:00AM
Nov-09-22 08:32AM
Nov-08-22 10:00AM
07:55AM
Nov-03-22 10:00AM
National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate and Other. The Owned and Host segment offers America's Best and Eyeglass World brands. The Legacy segment includes inventory and lab processing services. The Corporate and Other segment relates to the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Clark Bill SVP, Chief People Officer Mar 05 '24 Option Exercise 0.00 2,556 0 32,925 Mar 07 04:17 PM Acharya Ravi SVP, Chief Technology Officer Mar 05 '24 Option Exercise 0.00 2,556 0 16,563 Mar 07 04:19 PM Rasmussen Melissa Chief Financial Officer Mar 05 '24 Option Exercise 0.00 1,279 0 21,689 Mar 07 04:16 PM Moore Patrick R. Chief Operating Officer Mar 05 '24 Option Exercise 0.00 5,111 0 64,708 Mar 07 04:13 PM Brandman Jared SVP, GC and Secretary Mar 05 '24 Option Exercise 0.00 2,556 0 36,030 Mar 07 04:15 PM FAHS L READE Chief Executive Officer Mar 05 '24 Option Exercise 0.00 20,078 0 619,089 Mar 07 04:11 PM Moore Patrick R. Chief Operating Officer Nov 18 '23 Option Exercise 0.00 2,745 0 49,619 Nov 21 04:31 PM Rasmussen Melissa Chief Financial Officer Nov 18 '23 Option Exercise 0.00 2,745 0 15,301 Nov 21 04:33 PM Moore Patrick R. Chief Operating Officer Oct 05 '23 Option Exercise 0.00 2,888 0 47,744 Oct 10 04:16 PM PEELER D RANDOLPH Director May 23 '23 Buy 25.73 17,609 453,080 148,880 May 24 04:42 PM PEELER D RANDOLPH Director May 22 '23 Buy 25.59 22,861 585,013 131,271 May 24 04:42 PM TAYLOR THOMAS V Director May 17 '23 Buy 24.04 2,079 49,979 25,556 May 19 04:30 PM FAHS L READE Chief Executive Officer May 15 '23 Buy 23.81 12,625 300,601 556,550 May 17 12:22 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite